This is exemplified in the work of Hancock et al. [56], who demonstrated that targeting of IKKα and IKKβ by miR-US5-1 and miR-UL112-3p was responsible for modulating proinflammatory cytokine levels during lytic infection using this approach. The gene discussed is IKBKB; the disease is infection.